Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Prospective, randomized, double-blinded, placebo-controlled clinical investigation of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo
Epistemonikos ID: c75dbad3b19f534671fc22ca41492b6daf7057d3
First added on: May 22, 2024